MICHAEL THASE: Open Payments
NPI 1982670279 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$70,709 in 40 payments from 7 companies in 2025. Trend: 2023 $75,063 · 2024 $65,224 · 2025 $70,709
Consulting: $25,998Speaker / faculty: $18,690Travel & lodging: $13,234Honoraria: $12,000Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| H. Lundbeck A S | 3 | $22,579 |
| Boehringer Ingelheim International GmbH | 6 | $21,218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $14,948 |
| E.R. Squibb & Sons, L.L.C. | 3 | $5,025 |
| ABBVIE INC. | 4 | $3,714 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $2,500 |
| Eli Lilly and Company | 1 | $725 |
Products named: CAPLYTA, QULIPTA, VRAYLAR.
Industry payments across PA — which companies pay providers there.
